Literature DB >> 6608007

Role of T-lymphocyte subsets in recovery from herpes simplex virus infection.

H S Larsen, M F Feng, D W Horohov, R N Moore, B T Rouse.   

Abstract

Our investigations probed the nature of different T-lymphocyte subsets effecting clearance of herpes simplex virus after infection of the pinna. Cell populations from animals recently infected subcutaneously or intraperitoneally (acute population) or from animals infected 6 weeks previously (primed population) or the latter cells reimmunized in vitro with virus (memory population) were studied. Viral clearance was a function of the Lyt 1+2- subset in the acute population, but with the memory population both Lyt 1+ and Lyt 2+ cells affected clearance. In primed populations, viral clearance was effected only by the Lyt 2+ subset. The ability of the various cell populations to adoptively transfer delayed-type hypersensitivity was also studied. Only acute population cells from animals infected subcutaneously and memory population cells transferred delayed-type hypersensitivity. In both cases, the cell subtype was Lyt 1+2-. Our results demonstrated that the delayed-type hypersensitivity response does not always correlate with immunity to herpes simplex virus. Multiple subsets of T cells participate in viral clearance, and their respective importances vary according to the stage of the virus-host interaction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608007      PMCID: PMC255581     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells.

Authors:  K Pfizenmaier; A Starzinski-Powitz; M Röllinghoff; D Falks; H Wagner
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

2.  Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice.

Authors:  S Nagafuchi; H Oda; R Mori; T Taniguchi
Journal:  J Gen Virol       Date:  1979-09       Impact factor: 3.891

3.  MHC matching shows that at least two T-cell subsets determine resistance to HSV.

Authors:  E L Howes; W Taylor; N A Mitchison; E Simpson
Journal:  Nature       Date:  1979-01-04       Impact factor: 49.962

4.  A temperature-sensitive mutant of herpes simplex virus type 1 defective in the synthesis of the major capsid polypeptide.

Authors:  D R Bone; R J Courtney
Journal:  J Gen Virol       Date:  1974-07       Impact factor: 3.891

5.  Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus.

Authors:  A A Nash; P G Gell
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

6.  Delayed hypersensitivity in the mouse.

Authors:  A J Crowle
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

7.  Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells.

Authors:  M J Lawman; R J Courtney; R Eberle; P A Schaffer; M K O'Hara; B T Rouse
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

8.  Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.

Authors:  A A Nash; N P Ashford
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

9.  Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.

Authors:  H S Larsen; R G Russell; B T Rouse
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  H-2 restriction of virus-specific T-cell-mediated effector functions in vivo. II. Adoptive transfer of delayed-type hypersensitivity to murine lymphocytic choriomeningits virus is restriced by the K and D region of H-2.

Authors:  R M Zinkernagel
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more
  19 in total

1.  Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.

Authors:  M J Reddehase; F Weiland; K Münch; S Jonjic; A Lüske; U H Koszinowski
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

3.  Regulation of herpes simplex virus-specific lymphoproliferation by suppressor cells.

Authors:  D W Horohov; R N Moore; B T Rouse
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

4.  Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor.

Authors:  D W Horohov; J H Wyckoff; R N Moore; B T Rouse
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR.

Authors:  S Camelo; J Castellanos; M Lafage; M Lafon
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 6.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells.

Authors:  S Martin; B Moss; P W Berman; L A Laskey; B T Rouse
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

8.  Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro.

Authors:  B Wahren; P Ljungman; T Paulin; O Ringdén
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

9.  Role of Langerhans cells and Thy. 1+ effector cells in herpes simplex virus-1 infection in the skin of newborn mice.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

10.  T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees.

Authors:  J W Eichberg; J M Zarling; H J Alter; J A Levy; P W Berman; T Gregory; L A Lasky; J McClure; K E Cobb; P A Moran
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.